|
|
Volumn 16, Issue 7, 2015, Pages e318-
|
|
Combination immunotherapy breakthrough for melanoma
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
IPILIMUMAB;
MONOCLONAL ANTIBODY;
NIVOLUMAB;
COMPARATIVE STUDY;
CONTROLLED STUDY;
DISEASE FREE SURVIVAL;
DRUG COMBINATION;
FEMALE;
HUMAN;
IMMUNOTHERAPY;
MALE;
MELANOMA;
MORTALITY;
PATHOLOGY;
PROCEDURES;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIAL;
SKIN NEOPLASMS;
SURVIVAL;
TREATMENT OUTCOME;
TUMOR INVASION;
ANTIBODIES, MONOCLONAL;
DISEASE-FREE SURVIVAL;
DRUG THERAPY, COMBINATION;
FEMALE;
HUMANS;
IMMUNOTHERAPY;
MALE;
MELANOMA;
NEOPLASM INVASIVENESS;
PROGNOSIS;
SKIN NEOPLASMS;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
|
|
EID: 84942426057
PISSN: None
EISSN: 14745488
Source Type: Journal
DOI: 10.1016/S1470-2045(15)00030-3 Document Type: Article |
|
Times cited : (5)
|
|
References (0)
|